Savitz Adam

CHIEF MEDICAL OFFICERAlto Neuroscience, Inc. (ANRO) · full profile →Form 4 · filed Jul 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 3, 2025Disposed to issuer(D)76K0
Jul 3, 2025Grant(A)76K76K
Jul 3, 2025Disposed to issuer(D)73K0
Jul 3, 2025Grant(A)73K73K
Jul 3, 2025Disposed to issuer(D)124K0
Jul 3, 2025Grant(A)124K124K
Jul 3, 2025Disposed to issuer(D)33K0
Jul 3, 2025Grant(A)33K33K
Jul 3, 2025Disposed to issuer(D)22K0
Jul 3, 2025Grant(A)22K22K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999480-25-000064) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ANRO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001999480-25-000064"
Ask your agent
Use Arkolith to summarize insider buying and selling at Alto Neuroscience, Inc.
over the last 90 days and cite the filings.